7,206 press releases indexed under healthcare.
MIAMI, Sept. 4, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, has launched the Prevention, Accountability, Treatment & Healing (PATH) Program at the Stark County Jail in Canton, Ohio. Launched in July, the program offers a...
CHARLOTTE, N.C., Sept. 4, 2026 /PRNewswire/ -- TUSK Practice Sales ("TUSK"), the premier healthcare-focused M&A Advisor, released its Q3 2026 Behavioral Health Market Report. The report reviews transaction activity across the behavioral health industry from the first and second quarters...
MUMBAI, India and NAPLES, Fla., Sept. 4, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
PORTLAND, Ore. & LITTLE ROCK, Ark., September 04, 2026--The Arkansas Insurance Department has approved the strategic affiliation between Arkansas Blue Cross and Blue Shield and Cambia Health Solutions.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
Accreditation affirms MMRO's commitment to responsible AI governance, human oversight, and clinical integrity. NOVI, Mich., Sept. 4, 2026 /PRNewswire/ -- Managed Medical Review Organization, Inc. (MMRO) is proud to announce that it has earned the Artificial Intelligence in Health Care...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ:GUTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/fractyl-health-inc-guts-class_action_lawsuit. Fractyl Case ..
LOS ANGELES, Sept. 4, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. (HIMS) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH,...
Built for point-of-care diagnostics, automated slide imaging, and pathology vision systems that must resolve a specimen clearly regardless of exactly how it is presented, this camera pairs the Onsemi AR1335 monochrome sensor with VCM autofocus and an M12 lens mount over USB 3.2 Gen 1, giving medical diagnostic equipment manufacturers consistent focus without a fixed working distance assumption baked into the hardware.
RAANANA, ISRAEL, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the closing of its previously announced registered direct offering and concurrent private placement. The Company issued to a single institutional investor Ordinary Shares and pre-funded warrants in a registered direct offering. In a concurrent private placement, the Company also issued to the same investor pre-funded and investor warrants. Aggregate gross proceeds to the Company from both transactions were approximately $4.0 million.
(PR-inside.com) SHENZHEN, CHINA - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) received the approval from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (Lumirix®) for the treatment of mild to moderate atopic dermatitis (“AD”) on 2 September 2026. The drug registration certificate was obtained on 3 September 2026. The product is ..
London , UK, 2026-09-04 — /EPR Network/ — Life in London can be busy. Long work days, travel, and daily tasks can make people feel [read full press release...]